PMID: 8950679Nov 1, 1996Paper

Loss of heterozygosity in tuberous sclerosis hamartomas

Journal of Medical Genetics
T SeppA J Green

Abstract

We have previously described in tuberous sclerosis (TSC) hamartomas the phenomenon of loss of heterozygosity (LOH) for DNA markers in the region of both the TSC2 gene on chromosome 16p13.3 and the TSC1 gene on 9q34. We now describe the spectrum of LOH in 51 TSC hamartomas from 34 cases of TSC. DNA was extracted from leucocytes or normal paraffin embedded tissue, and from frozen paraffin embedded hamartoma tissue from the same patient. The samples were analysed for 11 markers spanning the TSC1 locus and nine markers spanning the TSC2 locus. Twenty-one of 51 hamartomas showed LOH (41%). There was significantly more LOH on 16p13.3, with 16 hamartomas showing LOH around TSC2, and five in the vicinity of TSC1. No hamartoma showed LOH for markers around both loci. All the areas of LOH on chromosome 9 were large, but the smallest region of overlap lay between the markers D9S149 and D9S114, providing independent evidence for the localisation of the TSC1 gene. These data show that LOH is a common finding in a wide range of hamartomas, affecting the same TSC locus in different lesions from the same patient but not affecting both loci. These data support the hypothesis that both the TSC genes act as tumour suppressors and that the manifes...Continue Reading

References

Apr 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·A G Knudson
Jul 7, 1995·The Journal of Biological Chemistry·R WieneckeJ E DeClue
Oct 1, 1994·Human Molecular Genetics·A J GreenJ R Yates
May 1, 1994·Annals of Human Genetics·S PoveyE B Robson

❮ Previous
Next ❯

Citations

Apr 17, 2008·Pediatric Radiology·Henry J Baskin
Nov 19, 2009·European Radiology·Anne-Kristin PossekelSandra Pauls
Feb 10, 2011·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Romina MoaveroPaolo Curatolo
Dec 15, 2007·Virchows Archiv : an International Journal of Pathology·Guido MartignoniFranco Bonetti
Sep 23, 1998·Molecular Medicine Today·J Young, S Povey
Nov 15, 2002·Clinical Genetics·T Tucker, J M Friedman
Sep 13, 2001·Journal of Cutaneous Pathology·P A Nguyen-VuR Wienecke
Nov 16, 2005·Nature Neuroscience·Sohail F TavazoieBernardo L Sabatini
Mar 20, 2010·Lymphatic Research and Biology·Thomas N DarlingJoel Moss
Sep 26, 2003·The American Journal of Surgical Pathology·Paola FrancalanciRenata Boldrini
Jan 4, 1998·Journal of Pediatric Hematology/oncology·J A Biegel
Jul 11, 2009·The American Journal of Dermatopathology·Denisa KacerovskaDmitry V Kazakov
Aug 26, 2004·Kidney International·John J Bissler, J Chris Kingswood
Dec 24, 1998·Journal of Medical Genetics·J B AliJ R Yates
Jun 8, 2012·American Journal of Physiology. Renal Physiology·Eric A ArmourKevin C Ess
Feb 25, 2011·BMC Medical Genetics·Garilyn M JentarraVinodh Narayanan
Feb 8, 2006·Neurosurgical Focus·Todd McCallDaniel W Fults
Feb 20, 2014·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Taohui OuyangJian Chen
Jul 13, 2000·Biochemical and Biophysical Research Communications·S IkedaS Seki
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·G RennebeckC L Walker
Apr 12, 2001·Ultrastructural Pathology·M Barnard, G Lajoie
Oct 24, 2015·American Journal of Medical Genetics. Part a·Rudolf Happle
Mar 22, 2016·Case Reports in Oncological Medicine·Douglas Kwazneski IiHarry Sell
May 4, 2012·Journal of the American Academy of Dermatology·Denisa KacerovskaDmitry V Kazakov
Dec 22, 1999·Pathology, Research and Practice·C RöckenA Roessner
Apr 16, 1998·The Journal of Investigative Dermatology·S PackT N Darling
Jan 8, 2008·The Lancet Oncology·Jaroslaw JozwiakPawel Wlodarski
Jul 20, 2007·Journal of the American Academy of Dermatology·Robert A SchwartzSergiusz Jóźwiak
Mar 16, 2007·Molecular and Cellular Neurosciences·Sakiko YasuiKousaku Ohno
Jan 26, 2007·Advances in Dermatology·Patricia M Witman
Jan 26, 2007·Advances in Dermatology·Thomas N Darling
Apr 30, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·John J BisslerNeil D Johnson
Nov 7, 2008·International Journal of Dermatology·Donatella SchenaGiampiero Girolomoni
Jul 30, 1999·Journal of the American Academy of Dermatology·R Happle
Mar 15, 2013·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·David M FelicianoAngelique Bordey
Jun 25, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ece D GamsizEric M Morrow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.